Dermatology Best Practice: Getting Beneath the Surface in Atopic Dermatitis: A Patient-Centered Approach to Optimize Outcomes

 


 

Activity Overview

The focus of this program will be to provide scientific updates and management tools to improve atopic dermatitis (AD) disease control, treatment adherence, and quality of life. AD in adults is often unrecognized, although evidence suggests this condition is more common and complex than previously thought due to differing phenotypes and potential endotypes that can have signifi­cant therapeutic implications. We will explore how utilization of all these factors in a targeted treatment plan can result in better outcomes for lifelong disease management. Research into the underlying mechanisms of AD has led to development of targeted therapies that have the potential to dramatically change the treatment paradigm.

We will first review current American Academy of Dermatology recommendations for the management of moderate-to-severe AD and then discuss how the newly-approved therapies can be integrated into the treatment decision-making process. Besides a multifactorial etiology, AD is also associated with serious comorbidities in adults, most notably a higher incidence of cardiovascu­lar disease and depression.

A multidisciplinary approach to AD will be presented to address the biological, psychological, behavioral, and dietary factors that affect AD and the supportive skills and education patients need to manage and cope with this pervasive condition. We will include a patient case in the program for discussion of how to apply the data to real-world multidisciplinary approaches for optimal pa­tient care.

Acknowledgement of Commercial Support

This program is supported by an independent educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.
 

Instructions for This Activity and Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, “educational content/video files” will be available for your reference.
  • In order to receive a CME/CE certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME/CE certificate upon completion of these steps.


Target Audience

This program is directed toward community dermatologists, allergists, immunologists, rheumatologists, and primary care physicians. Fellows, nurse practitioners, physician assistants, researchers, and other health care professionals interested in the treatment or management of AD are also invited to participate.

Learning Objectives

Upon completion of this program, participants will be able to:

  • List the scientific advances and improvements in our understanding of the pathogenesis of atopic dermatitis (AD)
  • Articulate the results of landmark clinical trials in AD in patients with moderate to severe disease
  • Individualize treatment plans for adults with moderate to severe AD based on current guideline recommendations
  • Explain how a multidisciplinary approach to care may improve patient outcomes in AD
  • Describe how to engage patients in shared decision-making regarding their AD treatment options to improve outcomes

Faculty, Staff, and Planners' Disclosures

Peter A. Lio, MD 
Clinical Assistant Professor of Dermatology and Pediatrics
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Disclosure: Grant/Research Support: 
AOBIOME, La Fondation pour la Dermatite Atopique; Consultant: Anacor/Pfizer, AOBiome, Galderma, IntraDerm, Johnson & Johnson, La Roche-Posay/L’Oreal, Menlo Therapeutics, Pierre Fabre Dermatologie, Realm Therapeutics, Regeneron/Sanofi, Theraplex, Valeant; Speaker's Bureau: Regeneron/ Sanofi, Anacor/ Pfizer, Pierre Fabre Dermatologie, Valeant, La Roche- Posay/L’Oreal; Stock/Shareholder: Odeza, Modernizing Medicine

The staff of PER® have no relevant financial relationships with commercial interests to disclose.
 

Accreditation/Designation of Credit

This program is jointly provided by Global Education Group and Physicians’ Education Resource®, LLC. AMA PRA Category 1 Credit™ is provided by Global Education Group.

Physician Accreditation Statement

This program has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Physicians’ Education Resource®, LLC. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this live program for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the program.

Nursing Continuing Education

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This educational program for 1.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the program.

Nurse Practitioner Continuing Education

This program has been planned and implemented in accordance with the accreditation standards of the American Association of Nurse Practitioners (AANP) through joint providership of Global Education Group and PER®. Global Education Group is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number: 1561024. This program is approved for 1.0 contact hour(s) which includes 0.0 hour(s) of pharmacology.

Activity ID #2464L.

This program was planned in accordance with AANP CE standards and policies.

Global Contact Information

For information about the approval and accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational program.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

Global Education Group (Global) requires instructors, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this program to disclose any real or apparent conflict of interest they may have as related to the content of this program. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Off-Label Disclosure and Disclaimer

This CME/CE program may or may not discuss investigational, unapproved, or off-label uses of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE program is for continuing medical and nursing education purposes only and is not meant to substitute for the independent clinical judgment of a physician or nurse relative to the diagnostic, treatment, and management options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of Physicians’ Education Resource®, LLC, or of the company that provided commercial support for this program.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this program is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this program should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Faculty and Staff Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose.

Physicians’ Education Resource®, LLC (PER®
Planning Staff—David Heckard; Maryjo Dixon, RPh; Gloria Lauria and Kate Bowen.

Global Education Group 
Kristen Delisi, NP; Lindsay Borvansky; Ashley Marostica, RN, MSN; Andrea Funk; and Liddy Knight

 






Become a Member

Forgot Password?
Filter By